Journal of Anesthesia

, Volume 29, Issue 1, pp 112–121 | Cite as

Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients

  • Efstratios Apostolakis
  • Nikolaos A. Papakonstantinou
  • Nikolaos G. Baikoussis
  • George Papadopoulos
Review Article


Thirty to fifty percent of critically ill patients admitted to the intensive care unit suffer from generalized neuromuscular weakness due to critical illness polyneuropathy, critical illness myopathy, or a combination of them, thus prolonging mechanical ventilation and their intensive care unit stay. A distinction between these syndromes and other neuromuscular abnormalities beginning either before or after ICU admission is necessary. These intensive care unit-related diseases are associated with both elevated mortality rates and increased morbidity rates. Generally, over 50 % of patients will completely recover. Most of them recover after 4–12 weeks, but some patients have been reported to keep on suffering from muscle weakness for at least 4 months. Prevention has a key role in the management of critical illness neuromuscular disorders, as no specific therapy has been suggested. Either prevention or aggressive treatment of sepsis can prevent critical illness polyneuropathy and critical illness myopathy. The dose and duration of the administration of neuromuscular blocking drugs should be limited, and their concurrent administration with corticosteroids should be avoided. Intensive insulin therapy has also been proven to reduce their incidence. Finally, early mobilization via active exercise or electrical muscle stimulation plays a significant role in their prevention.


Critical illness Paresis Intensive care unit Muscle weakness Neuromuscular diseases Rehabilitation 


  1. 1.
    Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005;11:126–32.CrossRefPubMedGoogle Scholar
  2. 2.
    Pandit L, Agrawal A. Neuromuscular disorders in critical illness. Clin Neurol Neurosurg. 2006;108:621–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Dhand UK. Clinical approach to the weak patient in the intensive care unit. Respir Care. 2006;51(9):1024–40.PubMedGoogle Scholar
  4. 4.
    Gorson KC, Ropper AH. Generalized paralysis in the intensive care unit: emphasis on the complications of neuromuscular blocking agents and corticosteroids. J Int Care Med. 1996;11:219–31.Google Scholar
  5. 5.
    De Jonghe B, Cook D, Sharshar T, Lefaucheur JP, Carlet J, Outin H. Acquired neuromuscular disorders in critically ill patients: a systematic review. Intensive Care Med. 1998;24:1242–50.CrossRefPubMedGoogle Scholar
  6. 6.
    MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus (letter). Lancet. 1977;2(8038):615.CrossRefPubMedGoogle Scholar
  7. 7.
    Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47(11):1223–31.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A. Critical illness myopathy and neuropathy. Lancet. 1996;347:1579–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patient with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000;26:1360–3.CrossRefPubMedGoogle Scholar
  10. 10.
    De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S, Groupe de Réflexion et d’Etude des Neuromyopathies en Réanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859–67.CrossRefPubMedGoogle Scholar
  11. 11.
    Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA. Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain. 1987;110:819–41.CrossRefPubMedGoogle Scholar
  12. 12.
    Witt NJ, Zochodne DW, Bolton CF, Grand’Maison F, Wells G, Young GB, Sibbald WJ. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991;99(1):176–84.CrossRefPubMedGoogle Scholar
  13. 13.
    Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32:140–63.CrossRefPubMedGoogle Scholar
  14. 14.
    Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl). 2003;106:75–82.Google Scholar
  15. 15.
    Hund E, Herkert M, Becker CM, Hacke W. A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy. Ann Neurol. 1997;40:539.Google Scholar
  16. 16.
    Hermans G, De Jonghe B, Bruyninck F, Van den Berghe G. Clinical review: critical illness polyneuropathy and myopathy. Crit Care. 2008;12:238–46.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996;24:1408–16.CrossRefPubMedGoogle Scholar
  18. 18.
    Morisaki H, Sibbald WJ. Tissue oxygen delivery and the microcirculation. Crit Care Clin. 2004;20:213–23.CrossRefPubMedGoogle Scholar
  19. 19.
    Bolton CF. Critical illness polyneuropathy. In: Thomas PK, Asbury A, editors. Peripheral nerve disorders II. Oxford: Butterworth-Heinemann; 1995. p. 262–80.Google Scholar
  20. 20.
    Di Giovanni S, Mirabella M, D’Amico A, Tonali P, Servidei S. Apoptotic features accompany acute quadriplegic myopathy. Neurology. 2000;55:854–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Essén P, McNurlan MA, Gamrin L, Hunter K, Calder G, Garlick PJ, Wernerman J. Tissue protein synthesis rates in critically ill patients. Crit Care Med. 1998;26:92–100.CrossRefPubMedGoogle Scholar
  22. 22.
    Monk DN, Plank LD, Franch-Arcas G, Finn PJ, Streat SJ, Hill GL. Sequential changes in the metabolic response in critically patients during the first 25 days after blunt trauma. Surgery. 1996;223:395–405.Google Scholar
  23. 23.
    Rich MN, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol. 1998;43:171–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Rich MN, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol. 2001;50:26–33.CrossRefPubMedGoogle Scholar
  25. 25.
    Rich MN, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol. 2003;547:555–66.CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar A, Garnacho-Montero MC, Moyano-Del-Estad MR. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27:1288–96.CrossRefPubMedGoogle Scholar
  27. 27.
    Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358:1327–35.CrossRefPubMedGoogle Scholar
  28. 28.
    Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33:1876–91.CrossRefPubMedGoogle Scholar
  29. 29.
    Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F, Busch T, Falke KJ, Kaisers U. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med. 2005;33:711–5.CrossRefPubMedGoogle Scholar
  30. 30.
    de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meché FG. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001;29(12):2281–6.CrossRefPubMedGoogle Scholar
  31. 31.
    De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30:1117–21.CrossRefPubMedGoogle Scholar
  32. 32.
    Leijten FS, de Weerd AW, Poortvliet DC, De Ridder VA, Ulrich C, Harink-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med. 1996;22:856–61.CrossRefPubMedGoogle Scholar
  33. 33.
    Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005;33:349–54.CrossRefPubMedGoogle Scholar
  34. 34.
    Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;274(15):1221–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med. 1998;24:801–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348–53.CrossRefPubMedGoogle Scholar
  37. 37.
    Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G. Impact of intensive insulin therapy on neuromuscular complications and ventilator-dependency in MICU. Am J Respir Crit Care Med. 2007;175:480–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Apte-Kakade F. Rehabilitation of patients with quadriparesis after treatment of status asthmaticus with neuromuscular blocking agents and high dose corticosteroids. Arch Phys Med Rehabil. 1991;72:1024–8.PubMedGoogle Scholar
  39. 39.
    Gorson KC, Ropper AH. Acute respiratory failure neuropathy: a variant of critical illness polyneuropathy. Crit Care Med. 1993;21:267–71.CrossRefPubMedGoogle Scholar
  40. 40.
    Gorson K. Approach to neuromuscular disorders in the intensive care unit. Neurocrit Care. 2005;03:195–212.CrossRefGoogle Scholar
  41. 41.
    Tepper M, Rakic S, Haas JA, Woittiez AJ. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med. 2000;56:211–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med. 2003;29:1505–14.CrossRefPubMedGoogle Scholar
  43. 43.
    Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic and pathological aspects. Ann Neurol. 1996;40:645–54.CrossRefPubMedGoogle Scholar
  44. 44.
    Zifko UA, Zipko HT, Bolton CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci. 1998;159(2):186–93.CrossRefPubMedGoogle Scholar
  45. 45.
    Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med. 1995;21(9):737–43.CrossRefPubMedGoogle Scholar
  46. 46.
    Bolton CF. Electrophysiologic studies of critically ill patients. Muscle Nerve. 1987;10(2):129–35.CrossRefPubMedGoogle Scholar
  47. 47.
    Bolton CF. AAEM minimonograph #40: clinical neurophysiology of the respiratory system. Muscle Nerve. 1993;16(8):809–18.CrossRefPubMedGoogle Scholar
  48. 48.
    Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. 2nd ed. Philadelphia: FA Davis; 1989.Google Scholar
  49. 49.
    Latronico N, Rasulo FA. Presentation and management of ICU myopathy and neuropathy. Curr Opin Crit Care. 2010;16(2):123–7.CrossRefPubMedGoogle Scholar
  50. 50.
    Stibler H, Edstrom L, Ahlbeck K, Remahl S, Ansved T. Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med. 2003;29(9):1515–27.CrossRefPubMedGoogle Scholar
  51. 51.
    Lefaucheur JP, Nordine T, Rodriguez P, Brochard L. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry. 2005;77:500–6.CrossRefPubMedCentralPubMedGoogle Scholar
  52. 52.
    Khan J, Burnham EL, Moss M. Acquired weakness in the ICU: critical illness myopathy and polyneuropathy. Minerva Anestesiol. 2006;72(6):401–6.PubMedGoogle Scholar
  53. 53.
    Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31:1012–6.CrossRefPubMedGoogle Scholar
  54. 54.
    Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med. 1992;327:524–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med. 1990;18:1177–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRefPubMedGoogle Scholar
  57. 57.
    Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. 2000;181:S462–72.CrossRefPubMedGoogle Scholar
  58. 58.
    Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med. 1997;23:1144–9.CrossRefPubMedGoogle Scholar
  59. 59.
    Wijdicks EFM, Fulgham JR. Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle Nerve. 1994;17:1494–5.PubMedGoogle Scholar
  60. 60.
    Martin UJ, Hincapie L, Nimchuk M, Gaughan J, Criner GJ. Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med. 2005;33:2259–65.CrossRefPubMedGoogle Scholar
  61. 61.
    Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T. Weaning from mechanical ventilation. Eur Respir J. 2007;29:1033–56.CrossRefPubMedGoogle Scholar
  62. 62.
    Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry. 1986;49:563–73.CrossRefPubMedCentralPubMedGoogle Scholar
  63. 63.
    Berard MP, Zazzo JF, Condat P, Vasson MP, Cynober L. Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit Care Med. 2000;28:3637–44.CrossRefPubMedGoogle Scholar
  64. 64.
    Yu YM, Ryan CM, Fei ZW, Lu XM, Castillo L, Schultz JT, Tompkins RG, Young VR. Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am J Physiol Endocrinol Metab. 2002;282:E247–58.PubMedGoogle Scholar
  65. 65.
    Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995;152:1268–74.CrossRefPubMedGoogle Scholar
  66. 66.
    Pichard C, Kyle U, Chevrolet JC, Jolliet P, Slosman D, Mensi N, Temler E, Ricou B. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study. Crit Care Med. 1996;24:403–13.CrossRefPubMedGoogle Scholar
  67. 67.
    Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med. 1996;153:1686–90.CrossRefPubMedGoogle Scholar
  68. 68.
    de Seze M, Petit H, Wiart L, Cardinaud JP, Gaujard E, Joseph PA, Mazaux JM, Barat M. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur Neurol. 2000;43:61–9.CrossRefPubMedGoogle Scholar
  69. 69.
    Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ. Acute myopathy after liver transplantation. Neurology. 1998;50:46–53.CrossRefPubMedGoogle Scholar
  70. 70.
    Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev 2004;(1):CD002243.Google Scholar
  71. 71.
    Hough CL, Steinberg KP, Taylor Thompson B, Rubenfeld GD, Hudson LD. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 2009;35(1):63–8.CrossRefPubMedCentralPubMedGoogle Scholar
  72. 72.
    Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082–8.CrossRefPubMedGoogle Scholar
  73. 73.
    Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277–86.CrossRefPubMedCentralPubMedGoogle Scholar
  74. 74.
    Hermans G, Schrooten M, Van Damme P, Berends N, Bouckaert B, De Vooght W, Robberecht W, Van den Berghe G. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care. 2009;13(1):R5.CrossRefPubMedCentralPubMedGoogle Scholar
  75. 75.
    Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.CrossRefPubMedGoogle Scholar
  76. 76.
    Schweickert WD, Kress JP. Implementing early mobilization interventions in mechanically ventilated patients in the ICU. Chest. 2011;140(6):1612–7.CrossRefPubMedGoogle Scholar
  77. 77.
    Bailey P, Thomsen GE, Spuhler VJ, Blair R, Jewkes J, Bezdjian L, Veale K, Rodriquez L, Hopkins RO. Early activity is feasible and safe in respiratory failure patients. Crit Care Med. 2007;35(1):139–45.CrossRefPubMedGoogle Scholar
  78. 78.
    Hanekom S, Gosselink R, Dean E, van Aswegen H, Roos R, Ambrosino N, Louw Q. The development of a clinical management algorithm for early physical activity and mobilization of critically ill patients: synthesis of evidence and expert opinion and its translation into practice. Clin Rehabil. 2011;25(9):771–87.CrossRefPubMedGoogle Scholar
  79. 79.
    Gosselink R, Bott J, Johnson M, Dean E, Nava S, Norrenberg M, Schönhofer B, Stiller K, van de Leur H, Vincent JL. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill patients. Intensive Care Med. 2008;34:1188–99.CrossRefPubMedGoogle Scholar
  80. 80.
    Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008;36(8):2238–43.CrossRefPubMedGoogle Scholar
  81. 81.
    Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–82.CrossRefPubMedGoogle Scholar
  82. 82.
    Thomsen GE, Snow GL, Rodriguez L, Hopkins RO. Patients with respiratory failure increase ambulation after transfer to an intensive care unit where early activity is a priority. Crit Care Med. 2008;36(4):1119–24.CrossRefPubMedGoogle Scholar
  83. 83.
    Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, Markaki V, Zervakis D, Nanas S. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74.CrossRefPubMedCentralPubMedGoogle Scholar
  84. 84.
    Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K, Vasileiadis I, Papadopoulos E, Mitsiou G, Tsimpouki D, Routsi C, Nanas S. Electrical muscle stimulation: an effective form of exercise and early mobilization to preserve muscle strength in critically ill patients. Crit Care Res Pract. 2012;2012:432752.PubMedCentralPubMedGoogle Scholar
  85. 85.
    Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, Chatzimichail A, Routsi C, Roussos C, Nanas S. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care. 2009;13(5):R161.CrossRefPubMedCentralPubMedGoogle Scholar
  86. 86.
    Magistris MR. Critical illness neuropathies. Rev Neurol (Paris). 2002;158:293–9.PubMedGoogle Scholar
  87. 87.
    Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care. 2005;11:381–90.CrossRefPubMedGoogle Scholar
  88. 88.
    Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS, Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683–93.CrossRefPubMedGoogle Scholar
  89. 89.
    Leijten FS. Survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348(21):2149–50.CrossRefPubMedGoogle Scholar
  90. 90.
    Bolton CF. The polyneuropathy of critical illness. J Intensive Care Med. 1994;9:132–8.Google Scholar
  91. 91.
    Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve Suppl. 2000;9:S49–52.CrossRefPubMedGoogle Scholar
  92. 92.
    van der Schaaf M, Beelen A, de Vos R. Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil. 2004;26:1189–97.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2014

Authors and Affiliations

  • Efstratios Apostolakis
    • 1
  • Nikolaos A. Papakonstantinou
    • 2
    • 5
  • Nikolaos G. Baikoussis
    • 3
  • George Papadopoulos
    • 4
  1. 1.Cardiothoracic Surgery DepartmentUniversity Hospital of Ioannina, School of MedicineIoanninaGreece
  2. 2.General Surgery DepartmentGeneral Oncological Hospital “Agioi Anargyroi”Kifisia, AthensGreece
  3. 3.Cardiac Surgery DepartmentL’Institut Mutualist MontsurisParis Cedex 14France
  4. 4.Department of AnesthesiologyUniversity Hospital of Ioannina, School of MedicineIoanninaGreece
  5. 5.AthensGreece

Personalised recommendations